Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 11 of 15 for:    "Guillain-Barre syndrome"

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by University of Cologne
Information provided by (Responsible Party):
Helmar Lehmann, University of Cologne Identifier:
First received: July 30, 2012
Last updated: May 27, 2014
Last verified: May 2014

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.

Guillain-Barre Syndrome
Multifocal Motor Neuropathy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

Resource links provided by NLM:

Further study details as provided by University of Cologne:

Estimated Enrollment: 50
Study Start Date: October 2012
Estimated Study Completion Date: June 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

patients with immune neuropathies


Inclusion Criteria:

  • immune neuropathy
  • age above 18 y
  • IVIg treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01655394

Contact: Helmar C. Lehmann, PD Dr. med.

University of Cologne Recruiting
Cologne, Germany
Contact: Helmar Lehmann, MD         
Sponsors and Collaborators
University of Cologne
Principal Investigator: Helmar C. Lehmann, PD Dr. med. PI
  More Information

No publications provided

Responsible Party: Helmar Lehmann, PD Dr. med. H. Lehmann, University of Cologne Identifier: NCT01655394     History of Changes
Other Study ID Numbers: 01607831337
Study First Received: July 30, 2012
Last Updated: May 27, 2014
Health Authority: Germany: University of Cologne

Additional relevant MeSH terms:
Guillain-Barre Syndrome
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Polyradiculoneuropathy processed this record on November 20, 2014